BSESkybiotech Healthcare LtdMinimalNeutral
Announced Thu, 25 Sept · 13:26 IST

Intimation regarding Trading Window Closure for approval of unaudited financial results of Company for the Quarter and half year ended 30th September, 2025

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Kapil Cotex Limited has informed BSE that its trading window for dealing in the company's shares will be closed starting October 1, 2025. The window will reopen only 48 hours after the company declares its unaudited financial results for the quarter and half year ended September 30, 2025. During this closure period, all designated persons and their immediate relatives are prohibited from trading in the company's securities. The board meeting date to consider and approve the Q2 FY26 results will be communicated to the stock exchange separately. The intimation has been signed by Prakashchandra Rathi, Director and CFO, and is filed under SEBI's Prohibition of Insider Trading Regulations, 2015.

Likely market impact

This is a routine compliance filing with no direct impact on shareholders or the stock price. However, it signals that the company's Q2 FY26 earnings announcement is approaching, which investors should watch for actual business updates.